GENE ONLINE|News &
Opinion
Blog

2021-10-12| Special

Are Digital Therapeutics the Next Generation of Medical Products?

by Sahana Shankar
Share To
Technology has made huge strides in not only health monitoring and disease diagnosis but also active therapeutics. It is a fast-growing health sector that has seen investments grow by 40% year on year since 2013.

A wide range of products backed by evidence and peer-reviewed studies are now available to address cognitive disorders like ADHD, autoimmune diseases, insomnia, and psychiatric disorders like schizophrenia. As a result, there is value for consumers (improved outcomes), physicians (real-time monitoring of symptoms), and investors (large market size), which can drive digital therapeutics for more cost-effective solutions in the future.

At the Biofuture conference, a panel consisting of diverse voices based on the broad spectrum of products in the digital therapeutics space discussed the evolution of digital therapeutics, how they serve unmet clinical needs, how they can redefine therapy/medicine in the future, and how to build successful and sustainable business models for the next generation of products.

GO Prime with only $1.49 now

LATEST
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
Global Trade Wars and Innovation Shake Up the Life Sciences Industry
2024-11-06
Antibody-Drug Conjugates: Connecting Drugs to Cancer Cells and Unlocking Billions in Market Opportunities
2024-11-06
Driving Post-Pandemic Growth: Navigating Pricing Pressures and the Rise of Generative AI
2024-11-06
Biotech on the Ballot: How the U.S. Presidential Election Puts Industry Policy to the Test
2024-11-06
The Golden Age of Medicine: Advancements in Novel Modalities and Therapeutic Areas
2024-11-01
Strengthening Biotech Ties: Highlights from the BioConnect Forum and Future Collaboration between Taiwan and Australia
2024-10-31
EVENT
Scroll to Top